2012
<i>Neisseria meningitis</i> serogroup X outbreak in Burkina Faso, 2009-2010
Yaro S, Drabo A, Ouangraoua S, Kirakoya-Samadoulougou F, Mueller J, Sanou O, Tall H, Jaillard P, Njanpop-Lafourcade B, Macq J, Robert A, Ouedraogo J. Neisseria meningitis serogroup X outbreak in Burkina Faso, 2009-2010. Open Journal Of Internal Medicine 2012, 2012: 41-49. DOI: 10.4236/ojim.2012.22010.Peer-Reviewed Original ResearchVaccine introductionPolymerase chain reactionSerogroup XPneumococcal vaccine introductionContacts of patientsReference laboratoryCountries' national guidelinesPilot districtsAdequate antibioticsCentre MurazCampaign vaccinationSecondary casesPolyvalent vaccineSerogroup distributionFluid collectionNational guidelinesVaccine compositionCSF samplesEpidemiological seasonFaster careLaboratory capacityAttack rateChain reactionBobo-DioulassoPatients
1987
The OCCGE (Organisation de Coordination et de Coopération pour la Lutte contre les Grandes Endémies) and the surveillance of the drug sensitivity of Plasmodium falciparum to antimalarials.
Gbary A, Guiguemde T, Ouedraogo J, Baudon D, Douchet C, Le Bras J, Breman J. The OCCGE (Organisation de Coordination et de Coopération pour la Lutte contre les Grandes Endémies) and the surveillance of the drug sensitivity of Plasmodium falciparum to antimalarials. Bulletin De La Société De Pathologie Exotique 1987, 80: 461-8. PMID: 3319256.Peer-Reviewed Original ResearchConceptsDifferent epidemiological featuresPrimary health careMalaria control strategiesCentre MurazEpidemiological featuresFebrile attacksSentinel centresReference centerAntimalarial drugsDrug sensitivityPlasmodium falciparumHealth careChemoresistanceSurveillanceSurveillance systemChemotherapyBurkina FasoChemosensitivityChloroquineAntimalarialsCareCenterFalciparum